MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,468M
Net Income
$691M
Net Profit Margin
28.00%
EPS
$1.65
Unit: Million (M) dollars
Revenue Breakdown
Parasiticides
Vaccines
Dermatology
Others
Revenue Breakdown
US
Other Emerging Markets
Other Developed Markets
Others
Revenue Breakdown
Dogs And Cats
Cattle
Swine
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
2,468
2,262
2,387
2,400
Cost of sales
673
641
712
683
Selling, general and administrative expenses
592
588
619
579
Research and development expenses
173
180
199
170
Amortization of intangible assets
31
31
31
32
Restructuring charges and certain acquisition and divestiture-related costs
77
22
17
4
Interest expense, net of capitalized interest
61
62
57
58
Other (income)/deductionsnet
5
20
9
13
Income before provision for taxes on income
866
758
761
887
Provision for taxes on income
175
157
158
166
Net income before allocation to noncontrolling interests
691
601
603
721
Less net income/(loss) attributable to noncontrolling interests
0
0
0
0
Net income attributable to zoetis inc
691
601
603
721
Basic EPS
1.65
1.42
1.376
1.63
Diluted EPS
1.65
1.42
1.375
1.63
Basic Average Shares
417,600,000
422,100,000
438,172,000
442,900,000
Diluted Average Shares
417,700,000
422,400,000
438,640,000
443,200,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
Parasiticides
$698M
(3.71%↑ Y/Y)
Vaccines
$521M
(3.37%↑ Y/Y)
Dermatology
$398M
(-14.04%↓ Y/Y)
Anti Infective
Products
$244M
(11.42%↑ Y/Y)
Pain Sedation
$217M
(0.00%↑ Y/Y)
Other
Pharmaceuticals
$168M
(-2.33%↓ Y/Y)
Animal Health
Diagnostics
$123M
(11.82%↑ Y/Y)
Other Non
Pharmaceuticals
$70M
(11.11%↑ Y/Y)
Total Productsand
Services
$2,439M
(0.54%↑ Y/Y)
Contract
Manufacturingand Human Health...
$29M
(-14.71%↓ Y/Y)
Revenue
$2,468M
(0.33%↑ Y/Y)
Other
(income)/deductionsnet
$5M
(225.00%↑ Y/Y)
Income before
provision for taxes on...
$866M
(-3.99%↓ Y/Y)
Cost of sales
$673M
(3.70%↑ Y/Y)
Selling, general and
administrative expenses
$592M
(-4.05%↓ Y/Y)
Research and development
expenses
$173M
(0.58%↑ Y/Y)
Restructuring charges and
certain acquisition and...
$77M
(156.67%↑ Y/Y)
Interest expense, net of
capitalized interest
$61M
(15.09%↑ Y/Y)
Amortization of intangible
assets
$31M
(-6.06%↓ Y/Y)
Net income before
allocation to...
$691M
(-3.76%↓ Y/Y)
Provision for taxes on
income
$175M
(-4.89%↓ Y/Y)
Net income
attributable to zoetis inc
$691M
(-3.76%↓ Y/Y)
Buy us a coffee
zoetis-investors-svg
Zoetis Inc. (ZTS)
zoetis-investors-svg
Zoetis Inc. (ZTS)